Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

  • Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancer.
    R Hui, A L Cornish, R A McClelland, J F Robertson, R W Blamey, E A Musgrove, R I Nicholson and R L Sutherland
    Clin Cancer Res June 1 1996 2 (6) 923-928;

  • Telomerase activity in human bladder cancer.
    Y Lin, H Miyamoto, K Fujinami, H Uemura, M Hosaka, Y Iwasaki and Y Kubota
    Clin Cancer Res June 1 1996 2 (6) 929-932;

  • Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy.
    J E Mortimer, F Dehdashti, B A Siegel, J A Katzenellenbogen, P Fracasso and M J Welch
    Clin Cancer Res June 1 1996 2 (6) 933-939;

  • Phase II study of 3-hour infusion of paclitaxel in previously untreated non-small cell lung cancer.
    I Sekine, Y Nishiwaki, K Watanabe, S Yoneda and N Saijo
    Clin Cancer Res June 1 1996 2 (6) 941-945;

  • Safety of autotransplants with high-dose melphalan in renal failure: a pharmacokinetic and toxicity study.
    G Tricot, D S Alberts, C Johnson, D J Roe, R T Dorr, D Bracy, D H Vesole, S Jagannath, R Meyers and B Barlogie
    Clin Cancer Res June 1 1996 2 (6) 947-952;

  • Murine and human in vivo penclomedine metabolism.
    N R Hartman, S O'Reilly, E K Rowinsky, J M Collins and J M Strong
    Clin Cancer Res June 1 1996 2 (6) 953-962;

  • Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial results.
    M T Brown, R E Coleman, A H Friedman, H S Friedman, R E McLendon, R Reiman, G J Felsberg, R D Tien, S H Bigner, M R Zalutsky, X G Zhao, C J Wikstrand, C N Pegram, J E Herndon 2nd, N A Vick, N Paleologos, R K Fredericks, S C Schold Jr and D D Bigner
    Clin Cancer Res June 1 1996 2 (6) 963-972;

  • Retroviral transfer of the human MDR1 gene confers resistance to bisantrene-specific hematotoxicity.
    I Aksentijevich, C O Cardarelli, I Pastan and M M Gottesman
    Clin Cancer Res June 1 1996 2 (6) 973-980;

  • In vivo modulation of iododeoxyuridine metabolism and incorporation into cellular DNA by 5'-amino-5'-deoxythymidine in normal mouse tissues and two human colon cancer xenografts.
    T J Kinsella, M C Glennon, K A Kunugi and M J Lindstrom
    Clin Cancer Res June 1 1996 2 (6) 981-989;

  • Stimulation of cis-diamminedichloroplatinum(II) accumulation by modulation of passive permeability with genistein: an altered response in accumulation-defective resistant cells.
    G Marverti and P A Andrews
    Clin Cancer Res June 1 1996 2 (6) 991-999;

  • Cytolysis of tumor cells expressing the Neu/erbB-2, erbB-3, and erbB-4 receptors by genetically targeted naive T lymphocytes.
    U Altenschmidt, R Kahl, D Moritz, B S Schnierle, B Gerstmayer, W Wels and B Groner
    Clin Cancer Res June 1 1996 2 (6) 1001-1008;

  • Evaluation of transferrin and gallium-pyridoxal isonicotinoyl hydrazone as potential therapeutic agents to overcome lymphoid leukemic cell resistance to gallium nitrate.
    C R Chitambar, P Boon and J P Wereley
    Clin Cancer Res June 1 1996 2 (6) 1009-1015;

  • Inhibition of the growth of glioblastomas by CGP 41251, an inhibitor of protein kinase C, and by a phorbol ester tumor promoter.
    M Begemann, S A Kashimawo, Y A Choi, S Kim, K M Christiansen, G Duigou, M Mueller, I Schieren, S Ghosh, D Fabbro, N M Lampen, D F Heitjan, P B Schiff, J N Bruce and I B Weinstein
    Clin Cancer Res June 1 1996 2 (6) 1017-1030;

  • In vitro stimulation of erythropoiesis by stem cell factor alone in myelodysplastic syndrome patients with elevated endogenous erythropoietin serum levels.
    H Zwierzina, T Bammer, I Rollinger-Holzinger, M Herold, P Fenaux, V Nüssler, E Hoflehner and D Geissler
    Clin Cancer Res June 1 1996 2 (6) 1031-1038;

  • Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23.
    W J Ellis, R L Vessella, K R Buhler, F Bladou, L D True, S A Bigler, D Curtis and P H Lange
    Clin Cancer Res June 1 1996 2 (6) 1039-1048;

  • Overexpression of the c-myc proto-oncogene in colorectal carcinoma is associated with a reduced mortality that is abrogated by point mutation of the p53 tumor suppressor gene.
    D R Smith and H S Goh
    Clin Cancer Res June 1 1996 2 (6) 1049-1053;

  • Predictive value of p53 mutations analyzed in bladder washings for progression of high-risk superficial bladder cancer.
    J A Vet, J A Witjes, S A Marras, D Hessels, H G van der Poel, F M Debruyne and J A Schalken
    Clin Cancer Res June 1 1996 2 (6) 1055-1061;

  • Relationship between platinum-DNA adducts in leukocytes of patients with advanced germ cell cancer and survival.
    M J Fisch, K L Howard, L H Einhorn and G W Sledge
    Clin Cancer Res June 1 1996 2 (6) 1063-1066;

  • Recurrence and death in non-small cell lung carcinomas: a prognostic model using pathological parameters, microvessel count, and gene protein products.
    G Fontanini, S Vignati, D Bigini, A Mussi, M Lucchi, S Chiné, C A Angeletti and G Bevilacqua
    Clin Cancer Res June 1 1996 2 (6) 1067-1075;

  • Expression of retinoic acid receptor beta in human renal cell carcinomas correlates with sensitivity to the antiproliferative effects of 13-cis-retinoic acid.
    A D Hoffman, D Engelstein, T Bogenrieder, C N Papandreou, E Steckelman, A Dave, R J Motzer, E Dmitrovsky, A P Albino and D M Nanus
    Clin Cancer Res June 1 1996 2 (6) 1077-1082;

  • Molecular staging of non-small cell lung cancer according to K-ras genotypes.
    R Rosell, M Monzó, A Pifarré, A Ariza, J J Sánchez, I Moreno, J Maurel, M P López, A Abad and J M de Anta
    Clin Cancer Res June 1 1996 2 (6) 1083-1086;

Back to top
PreviousNext
June 1996
Volume 2, Issue 6
  • Table of Contents
  • Table of Contents (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Advertisement
  • Most Cited
  • Most Read
Loading
  • scRNA-seq Analysis of Gastric Cancer TME
  • Toxicity Management Affects Checkpoint Inhibitor Efficacy
  • PDAC and GATA6 Expression
  • Rucaparib in mCRPC with a Non-BRCA DDR Gene Alteration
  • AR Gene Rearrangements in Prostate Cancer
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement